Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Xiamen Voke Mold & Plastic Engineering Co. Ltd. stock ¥32.86, price ¥60.00, that is 45.2% below the price, quality 61 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
58‑month range ¥17.13 – ¥160.23 · fair‑value band ¥24.64 – ¥41.07 · the ¥60.00 price screens above the ¥32.86 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow Xiamen Voke Mold & Plastic Engineering Co. in your weekly email
Every Wednesday you see whether Xiamen Voke Mold & Plastic Engineering Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Xiamen Voke Mold & Plastic Engineering Co., Ltd. engages in the research, development, design, manufacture, and sale of various injection molds in China and internationally.
Show moreShow less
It provides car central housing control, car air outlet housing, grille, engine connection body, air outlet high-gloss panel, car button two-color mold, six fuel tank two-color housing, car panel housing, steering wheel airbag, car dashboard housing, automobile instrument internal structural parts housing, car glove box housing, and automobile electric tailgate spring sleeve, used in automotive field.
It also provides electronic cigarette shell, pen cap, micro injection - hearing aid, optical cable communication shell, electronic connector, and 5G communication base station cooling fan products for use in electronic field; tool box, insulation box, multi-cavity cosmetic mold, baby carriage decorative cover shell, and baby wheel hub housing products used in home filed; and analysis box shell, medical laryngeal mask, medical oxygen mask, medical breathing ball, bed drive, and silicone oxygen mask for other markets.
Additionally, the company engages in the manufacturing of professional medical devices, specializing in the production of manual resuscitators and their accessories. The company was founded in 2005 and is headquartered in Xiamen City, China.
Stock analysis
Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196) currently trades at ¥60.00, while our model-based Fair Value estimate is ¥32.86, 45% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥48.15 per share, and 2 of the 16 models we run sit above the ¥60.00 price.
Bear case: the Dividend Discount group reads lowest at ¥6.16, and 14 of the 16 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥24.64 (bear) to ¥41.07 (bull), the price of ¥60.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Industrials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Xiamen Voke Mold & Plastic Engineering Co. Ltd. reported revenue of 2.2B CNY in FY2025 versus 1.2B CNY in FY2021, a compound +17.4%/yr. Reported net income was 257M CNY in FY2025, compounding +7.6%/yr from FY2021.
Key figures
Market cap 10.9B CNY (≈ $1.6B) Small · P/E ratio 35.1 · P/S ratio 3.77 · EPS (TTM) ¥1.71 · Dividend yield 0.9% · Net margin 9.7% · Return on equity 8.5% · Return on assets (EBIT) 7.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 63% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −38% fair-value upside, at −45%, 301196 screens richer than that median.
Fair Value models
Bear¥24.64Fair Value ¥32.86Bull¥41.07
Price ¥60.00 · Downside -45.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥1.00 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+21.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.3%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.5%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+9.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+8.3%
Dividend (yield on the price)0.9%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.21% → 14%
2025 sits 52% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Compare Xiamen Voke Mold & Plastic Engineering Co. Ltd. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Metal Fabrication · 259 stocks
Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score61 · Top 25%
Fair Value upside−45.2% · Below median
Profitability
Return on equity (12 months)8.5% · Above median
Return on assets6.0% · Top 25%
Net margin (12 months)9.7% · Top 25%
Operating margin (12 months)16.4% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)62.4% · Top 25%
Dividend yield (12 months)0.9% · Below median
Balance sheet
Debt / equity0.01× · Lowest 25%
Valuation Multiplesvs Metal Fabrication median · lower = cheaper
P/E (12 months)35.1× · Pricier than median
P/B3.25× · Priciest 25%
P/S (12 months)3.77× · Priciest 25%
EV/EBITDA22.0× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 69
PAST (return on equity)34· sector 24
HEALTH (low debt)99· sector 95
DIVIDEND (yield)18· sector 25
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of ¥32.86 versus a price of ¥60.00, about 45% lower (overvalued).
What is the fair value of 301196?
Our model-based fair value for Xiamen Voke Mold & Plastic Engineering Co. Ltd. is ¥32.86 (as of Nov 5, 2026), built from audited fundamentals. The current price: ¥60.00.
What is the quality score of 301196?
Xiamen Voke Mold & Plastic Engineering Co. Ltd. has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
Our model-based price target is the fair value of ¥32.86 (as of Nov 5, 2026) from 16 valuation models. Cautious scenario ¥24.64, optimistic scenario ¥41.07. It is a calculation from audited fundamentals, not an analyst target.
What is the Xiamen Voke Mold & Plastic Engineering Co. Ltd. stock forecast for 2026?
Our models put fair value at ¥32.86, about 45% lower versus a price of ¥60.00 (overvalued). Cautious scenario ¥24.64, optimistic scenario ¥41.07. The calculation is refreshed regularly with new filings.
What is the revenue of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
Xiamen Voke Mold & Plastic Engineering Co. Ltd. reported trailing-twelve-month revenue of about 2.9B CNY (latest available figure, as of Nov 5, 2026).
Does Xiamen Voke Mold & Plastic Engineering Co. Ltd. pay a dividend?
Xiamen Voke Mold & Plastic Engineering Co. Ltd. currently shows a dividend yield of 0.90% relative to its recent price (as of Nov 5, 2026).
How much is the dividend of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196) and when is the ex-dividend date?
Xiamen Voke Mold & Plastic Engineering Co. Ltd. pays a dividend of ¥0.539 per share a year, a dividend yield of 0.9%. The last ex-dividend date was Jun 24, 2026. A dividend has been paid every year since at least 2022. The payout ratio is 31.5% of earnings. Our assessment: Token dividend. At a yield of 0.9% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.9% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Xiamen Voke Mold & Plastic Engineering Co. Ltd. it is ¥32.86 per share (as of Nov 5, 2026), against a price of ¥60.00. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Xiamen Voke Mold & Plastic Engineering Co. Ltd. stock overvalued or undervalued in 2026?
As of Nov 5, 2026, 301196 trades above its calculated fair value: price ¥60.00, fair value ¥32.86, a gap of about −45% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301196?
No. The price is what the market pays today (¥60.00); the fair value is what the company's own numbers justify (¥32.86). For Xiamen Voke Mold & Plastic Engineering Co. Ltd. the two are ¥27.14 per share apart. That gap is exactly why we show both numbers side by side.
How much is Xiamen Voke Mold & Plastic Engineering Co. Ltd. worth?
The market values Xiamen Voke Mold & Plastic Engineering Co. Ltd. at about 10.9B CNY (market capitalisation, as of Nov 5, 2026). Per share that is ¥60.00; our models calculate a fair value of ¥32.86 per share.
What do the bullish and bearish scenarios say about 301196?
Our models span a range for Xiamen Voke Mold & Plastic Engineering Co. Ltd.: cautious scenario ¥24.64, base ¥32.86, optimistic ¥41.07 per share (as of Nov 5, 2026, price ¥60.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 301196?
Xiamen Voke Mold & Plastic Engineering Co. Ltd. trades at a price-to-earnings ratio of 35.1 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥32.86 is built from several models across several years. Other multiples: P/B 3.3, P/S 3.8, EV/EBITDA 22.0.
How solid is the balance sheet of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
Balance-sheet figures for Xiamen Voke Mold & Plastic Engineering Co. Ltd. (as of Nov 5, 2026): return on equity 8.5%, debt of 0.01 per unit of equity. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is 301196 from its 52-week high?
Xiamen Voke Mold & Plastic Engineering Co. Ltd. trades at ¥60.00, about 63% below its 52-week high of ¥160.23 and 13% above the low of ¥52.92 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥32.86 is for.
Which stocks are comparable to Xiamen Voke Mold & Plastic Engineering Co. Ltd.?
From the same area (Industrials) we also value ATI Inc, Carpenter Technology Corporation, Mueller Industries, Inc, Bharat Forge Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Xiamen Voke Mold & Plastic Engineering Co. Ltd. stock attractive at the current price?
The data as of Nov 5, 2026: price ¥60.00, calculated fair value ¥32.86 (−45%), Quality Score 61/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301196 calculated?
We run Xiamen Voke Mold & Plastic Engineering Co. Ltd. through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥32.86 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Xiamen Voke Mold & Plastic Engineering Co. Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
The closing price on Nov 6, 2026 was ¥60.00. Our model-based fair value is ¥32.86, about 45% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Xiamen Voke Mold & Plastic Engineering Co. Ltd. right now?
The price sits above even our optimistic bull case (¥41.07). The favourable scenario is already priced in. Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder.
How large is the market capitalisation of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
The market capitalisation of Xiamen Voke Mold & Plastic Engineering Co. Ltd. is 10.9B CNY (≈ $1.6B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
The price-to-sales ratio of Xiamen Voke Mold & Plastic Engineering Co. Ltd. is 3.77 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
Earnings per share at Xiamen Voke Mold & Plastic Engineering Co. Ltd. are ¥1.71 (price ÷ EPS = P/E 35.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
The dividend yield of Xiamen Voke Mold & Plastic Engineering Co. Ltd. is 0.9% (payout 31.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
The net margin of Xiamen Voke Mold & Plastic Engineering Co. Ltd. is 9.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
The return on equity (ROE) of Xiamen Voke Mold & Plastic Engineering Co. Ltd. is 8.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
On an EBIT basis the return on assets of Xiamen Voke Mold & Plastic Engineering Co. Ltd. is 7.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
The operating margin of Xiamen Voke Mold & Plastic Engineering Co. Ltd. is 16.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
Revenue at Xiamen Voke Mold & Plastic Engineering Co. Ltd. is growing +62.4% versus a year earlier (3y avg +32.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196)?
Earnings per share at Xiamen Voke Mold & Plastic Engineering Co. Ltd. are growing +42.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196) generate?
The free cash flow of Xiamen Voke Mold & Plastic Engineering Co. Ltd. is −1.6M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Xiamen Voke Mold & Plastic Engineering Co. Ltd. (301196) hold?
Xiamen Voke Mold & Plastic Engineering Co. Ltd. holds more cash than debt, 397M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Xiamen Voke Mold & Plastic Engineering Co. Ltd. in the live analysis
One click puts Xiamen Voke Mold & Plastic Engineering Co. Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 5, 2026